Literature DB >> 19015066

Origin of renal cell carcinomas.

Manuel Valladares Ayerbes1, Guadalupe Aparicio Gallego, Silvia Díaz Prado, Paula Jiménez Fonseca, Rosario García Campelo, Luis Miguel Antón Aparicio.   

Abstract

Cancer is a heritable disorder of somatic cells: environment and heredity are both important in the carcinogenic process. The primal force is the "two hits" of Knudson's hypothesis, which has proved true for many tumours, including renal cell carcinoma. Knudson et al. [1, 2] recognised that familial forms of cancer might hold the key to the identification of important regulatory elements known as tumour-suppressor genes. Their observations (i.e., that retinoblastoma tend to be multifocal in familial cases and unifocal in sporadic presentation) led them to propose a two-hit theory of carcinogenesis. Furthermore, Knudson postulated that patients with the familial form of the cancer would be born with one mutant allele and that all cells in that organ or tissue would be at risk, accounting for early onset and the multifocal nature of the disease. In contrast, sporadic tumours would develop only if a mutation occurred in both alleles within the same cell, and, as each event would be expected to occur with low frequency, most tumours would develop late in life and in a unifocal manner [3, 4]. The kidney is affected in a variety of inherited cancer syndromes. For most of them, both the oncogene/tumour-suppressor gene involved and the respective germline mutations have been identified. Each of the inherited syndromes predisposes to distinct types of renal carcinoma. Families with hereditary predisposition to cancer continue to provide a unique opportunity for the identification and characterisation of genes involved in carcinogenesis. A surprising number of genetic syndromes predispose to the development of renal cell carcinoma, and genes associated with five of these syndromes have been already identified: VHL, MET, FH, BHD and HRPT2. Few cancers have as many different types of genetic predisposition as renal cancer, although to date only a small proportion of renal cell cancers can be explained by genetic predisposition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19015066     DOI: 10.1007/s12094-008-0276-8

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  87 in total

Review 1.  Stem cells in the kidney.

Authors:  Qais Al-Awqati; Juan A Oliver
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

2.  C-met proto-oncogene expression in benign and malignant human renal tissues.

Authors:  L L Pisters; A K el-Naggar; W Luo; A Malpica; S H Lin
Journal:  J Urol       Date:  1997-09       Impact factor: 7.450

3.  CD34 expression as a novel marker of transformed mesangial cells in biopsied glomerular diseases.

Authors:  K Naruse; M Fujieda; E Miyazaki; Y Hayashi; N Kuroda; H Nakayama; H Kiyoku; M Hiroi; T Kurashige; H Enzan
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

Review 4.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

Review 5.  von Hippel-Lindau disease.

Authors:  V Couch; N M Lindor; P S Karnes; V V Michels
Journal:  Mayo Clin Proc       Date:  2000-03       Impact factor: 7.616

6.  Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan.

Authors:  B Zbar; T Kishida; F Chen; L Schmidt; E R Maher; F M Richards; P A Crossey; A R Webster; N A Affara; M A Ferguson-Smith; H Brauch; D Glavac; H P Neumann; S Tisherman; J J Mulvihill; D J Gross; T Shuin; J Whaley; B Seizinger; N Kley; S Olschwang; C Boisson; S Richard; C H Lips; M Lerman
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

7.  Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas.

Authors:  J Lubinski; P Hadaczek; J Podolski; A Toloczko; A Sikorski; P McCue; T Druck; K Huebner
Journal:  Cancer Res       Date:  1994-07-15       Impact factor: 12.701

8.  Tissue-specific expression of a constitutional 3;6 translocation: development of multiple bilateral renal-cell carcinomas.

Authors:  G Kovacs; P Brusa; W De Riese
Journal:  Int J Cancer       Date:  1989-03-15       Impact factor: 7.396

Review 9.  Hereditary renal cancers.

Authors:  Peter L Choyke; Gladys M Glenn; McClellan M Walther; Berton Zbar; W Marston Linehan
Journal:  Radiology       Date:  2003-01       Impact factor: 11.105

10.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

View more
  10 in total

Review 1.  Signaling pathways in renal cell carcinoma.

Authors:  Gowrishankar Banumathy; Paul Cairns
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

Review 2.  Long Non-Coding RNAs as Novel Biomarkers in the Clinical Management of Papillary Renal Cell Carcinoma Patients: A Promise or a Pledge?

Authors:  Francesco Trevisani; Matteo Floris; Riccardo Vago; Roberto Minnei; Alessandra Cinque
Journal:  Cells       Date:  2022-05-17       Impact factor: 7.666

Review 3.  Use of Circular RNAs in Diagnosis, Prognosis and Therapeutics of Renal Cell Carcinoma.

Authors:  Rebeca Osca-Verdegal; Jesús Beltrán-García; José Luis Górriz; José María Martínez Jabaloyas; Federico V Pallardó; José Luis García-Giménez
Journal:  Front Cell Dev Biol       Date:  2022-06-22

4.  β-catenin links von Hippel-Lindau to aurora kinase A and loss of primary cilia in renal cell carcinoma.

Authors:  Ruhee Dere; Ashley Lyn Perkins; Tasneem Bawa-Khalfe; Darius Jonasch; Cheryl Lyn Walker
Journal:  J Am Soc Nephrol       Date:  2014-10-13       Impact factor: 10.121

5.  Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinoma.

Authors:  Zachary S Morris; Andrea I McClatchey
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-01       Impact factor: 11.205

6.  In vivo clonal analysis reveals lineage-restricted progenitor characteristics in mammalian kidney development, maintenance, and regeneration.

Authors:  Yuval Rinkevich; Daniel T Montoro; Humberto Contreras-Trujillo; Orit Harari-Steinberg; Aaron M Newman; Jonathan M Tsai; Xinhong Lim; Renee Van-Amerongen; Angela Bowman; Michael Januszyk; Oren Pleniceanu; Roel Nusse; Michael T Longaker; Irving L Weissman; Benjamin Dekel
Journal:  Cell Rep       Date:  2014-05-15       Impact factor: 9.423

7.  Comprehensive analysis of 5-aminolevulinic acid dehydrogenase (ALAD) variants and renal cell carcinoma risk among individuals exposed to lead.

Authors:  Dana M van Bemmel; Paolo Boffetta; Linda M Liao; Sonja I Berndt; Idan Menashe; Meredith Yeager; Stephen Chanock; Sara Karami; David Zaridze; Vsevolod Matteev; Vladimir Janout; Hellena Kollarova; Vladimir Bencko; Marie Navratilova; Neonilia Szeszenia-Dabrowska; Dana Mates; Alena Slamova; Nathaniel Rothman; Summer S Han; Philip S Rosenberg; Paul Brennan; Wong-Ho Chow; Lee E Moore
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

8.  Compound C Inhibits Renca Renal Epithelial Carcinoma Growth in Syngeneic Mouse Models by Blocking Cell Cycle Progression, Adhesion and Invasion.

Authors:  Myungyeon Lee; Na Yeon Ham; Chi Yeon Hwang; Jiwon Jang; Boram Lee; Joo-Won Jeong; Insug Kang; Eui-Ju Yeo
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

9.  Renal cell carcinoma of the kidney with synchronous ipsilateral transitional cell carcinoma of the renal pelvis.

Authors:  Dogan Atilgan; Nihat Uluocak; Bekir Suha Parlaktas
Journal:  Case Rep Urol       Date:  2013-06-13

10.  TGR5 expression in normal kidney and renal neoplasms.

Authors:  Chaohui Lisa Zhao; Ali Amin; Yiang Hui; Dongfang Yang; Weibiao Cao
Journal:  Diagn Pathol       Date:  2018-04-02       Impact factor: 2.644

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.